| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/09/2005 | WO2005010032A3 Replikin peptides and uses thereof |
| 06/09/2005 | WO2005003302A3 Novel methods to modulate mast cells |
| 06/09/2005 | WO2005002513A3 C1q complement inhibitors and methods of use thereof |
| 06/09/2005 | WO2005000227A3 Methods of treating tnf-mediated disorders |
| 06/09/2005 | WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 06/09/2005 | WO2004108756A3 Sars coronavirus peptides and uses thereof |
| 06/09/2005 | WO2004107618A9 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 06/09/2005 | WO2004103288A3 Method of preventing recurrent miscarriages |
| 06/09/2005 | WO2004101756A3 Ovr110 antibody compositions and methods of use |
| 06/09/2005 | WO2004081177A3 Intracellular signaling pathways in diabetic subjects |
| 06/09/2005 | WO2004053102A3 Antibodies to treat cancer |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124794 Histidine-proline rich tropomyosin-related anti-angiogenic receptor polypeptide or peptide tor use in prevention and treatment of tumor |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124653 Prevention of cancer using chloroquinine compound; side effect reduction |
| 06/09/2005 | US20050124540 Antigens; induce immunology response; neutralizaton antibodies; prevent infections; diagnosis |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124041 Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124016 Antibodies specific for toxic amyloid beta protein oligomers |
| 06/09/2005 | US20050124012 Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123997 Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes |
| 06/09/2005 | US20050123996 Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| 06/09/2005 | US20050123991 Nucleotide sequences coding hydrolase capable of resolving enantiomeric mixtures of alcohol or ester substrates; for use in regio-and stereoselective biotransformations |
| 06/09/2005 | US20050123977 Using variation in tumor suppressor protein gene (p53) as diagnostic tool in detection and treatment of cell proliferative disorders |
| 06/09/2005 | US20050123973 Methods for generating monoclonal antibody against fusion protein containing peptide fragment derived from membrane protein |
| 06/09/2005 | US20050123961 Human G-protein coupled receptors |
| 06/09/2005 | US20050123935 For use in multicolor/multiplexing assays; bioconjugation; kits |
| 06/09/2005 | US20050123925 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123905 Relicating preferential nucleotide sequences using mixture comprising polymerase-amplified nucleic acid having a 5' overhang, a vector having a 3' overhang and an antibody that binds polymerase; improving exogenous gene expression |
| 06/09/2005 | US20050123900 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 06/09/2005 | US20050123594 contacting a liposome ( lectin, glycolipid, phospolipid) with RLIP76 protein to create a proteoliposome; detoxifies xenobiotics by a process that catalyzes ATP; protection against toxic by-products of metabolism, stress, and drugs |
| 06/09/2005 | US20050123586 Method for improving body weight uniformity and increasing carcass yield in animals |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123563 Lipoparticles comprising proteins, methods of making, and using the same |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123553 Immunogenic for use in diagnosis, vaccination and/or treatment of amyloid fibril disorders such as Alzheimers disease; vaccines |
| 06/09/2005 | US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
| 06/09/2005 | US20050123546 Polynucleotides; engineered Type II anti-CD20 antibodies with altered glycosylation; vectors and host cells; treatment of B cell lymphomas |
| 06/09/2005 | US20050123544 treating Alzheimer's disease by administering a humanized or chimeric antibody that specifically binds to an epitope within A beta 3-6 and monitoring the response |
| 06/09/2005 | US20050123543 With an integrin linked kinase (ILK) inhibitor which can be a peptide, an antibody, an antisense agent; optionally also treating with an ACE inhibitor; ACE (Angiotensin Converting Enzyme) |
| 06/09/2005 | US20050123542 Administering an IL-15 antagonist such as muteins or antibodies that induces apoptosis of monocytes to treat gout |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy |
| 06/09/2005 | US20050123539 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 06/09/2005 | US20050123538 nucleotide sequences that code human epidermal growth factor receptors, used for diagnosing and treating cancer |
| 06/09/2005 | US20050123537 Treating cancer and other angiogenic diseases |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | US20050123530 Stabilized proteins |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050122412 Digital camera |
| 06/09/2005 | DE10352977A1 Muriner anti Idiotyp-Antikörpers oder anti Idiotyp-Antikörper aus der Ratte des humanen monoklonalen SC-1 Antikörpers Murine anti-idiotype antibody, or anti-idiotype antibodies from the rat of the human monoclonal antibody SC-1 |
| 06/09/2005 | CA2552553A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | CA2547675A1 Antibodies binding to a c-terminal fragment of apolipoprotein e |
| 06/09/2005 | CA2547459A1 Modulators of nik-siva complex formation for treating immune disorders |
| 06/09/2005 | CA2547446A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | CA2547435A1 Targeting of erb antigens |
| 06/09/2005 | CA2547326A1 Novel muscle growth regulator |
| 06/09/2005 | CA2547165A1 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | CA2547126A1 Substance binding human igg fc receptor iib (fcyriib) |
| 06/09/2005 | CA2547034A1 Anticarcinoma antibodies and uses thereof |
| 06/09/2005 | CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | CA2546664A1 Anti-igfr1 antibody therapeutic combinations |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546580A1 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | CA2545867A1 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | CA2545653A1 Asymmetrically branched polymer conjugates and microarray assays |
| 06/09/2005 | CA2544532A1 Compositions comprising polypeptides |
| 06/09/2005 | CA2542546A1 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 06/08/2005 | EP1538207A1 Human antihuman mcp-1 antibody and antibody fragment thereof |
| 06/08/2005 | EP1538165A1 Inhibitors of glycoprotein VI based on monoclonal antibody hgp 5c4 |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537148A1 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/ or identifying neuronal precursor cells |
| 06/08/2005 | EP1537147A2 Antibody for adcc and inducing cytokine production |
| 06/08/2005 | EP1537141A1 Parathyroid hormone-like polypeptides |
| 06/08/2005 | EP1537140A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1536833A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 06/08/2005 | EP1536825A1 Interferon and immunoglobulin fc fragment hybrid |
| 06/08/2005 | EP1536820A2 Cancer therapy using whole glucan particles and antibodies |
| 06/08/2005 | EP1536814A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1399580A4 Secretion of proteins by encapsulated cells |